These were the biggest pharmaceutical deals in early 2022
Por um escritor misterioso
Descrição
GlobalData tracks the latest acquisitions, mergers, venture financing and asset transactions in the pharmaceutical sector.
Drug development – The four phases - BioStock
COVID-19 treatment Paxlovid has been free so far. Next year, sticker shock awaits
Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology
Can big pharma buy every biotech startup?
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis - The Lancet
Lilly scoops up Versanis in one of the top pharma deals of 2023
2023 Pharm Exec Top 50 Companies
2023 Pharm Exec Top 50 Companies
Top and emerging locations for M&A deals in the pharmaceutical industry - Pharmaceutical Technology
Pipelinepharma
Pharmaceutical market worldwide revenue 2001-2022
The top 10 drugs losing US exclusivity in 2023
The Impact of Pharmaceutical Wholesalers on U.S. Drug Spending
U.S. new drug price exceeds $200,000 median in 2022
de
por adulto (o preço varia de acordo com o tamanho do grupo)
